Nine of 63 companies object to their shares trading on OKXICE
- —Nine of 63 planned listings, or 14%, have objected
- —Objectors include Verizon, Broadcom, UnitedHealth, CoreWeave and Rocket Lab
- —Nasdaq also opted out, citing missing best-quote and consolidated trade data
- —OKXICE runs on XLayer with USDC and USDT settlement under an SEC Innovation Exemption
Why it matters: Issuer consent is emerging as a new gatekeeper for tokenized equities and could shrink the pool of tradable stocks for OKXICE and rivals.
Source: TokenPost